Heavy bleeding after birth linked to depression and anxiety risk

NCT ID NCT03120208

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 10, 2026 · Last updated Aug 06, 2026 · Updated 2 times

Summary

This study investigates whether women who experience heavy bleeding (postpartum hemorrhage) after childbirth are more likely to develop depression, anxiety, or stress in the following year. Researchers will follow over 1,200 women who had a hemorrhage and compare them to those who did not, using standard mental health questionnaires at 2, 6, and 12 months after delivery. The goal is to understand the psychological impact of this common birth complication.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If this study finds a link, it could lead to better screening and support for mental health after postpartum hemorrhage.
What could go wrong
This is an observational study, so it cannot prove cause and effect. Results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,298 people

The number who actually took part.

Started

Apr 2017

Finished

Apr 2020

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

For the women: Inclusion criteria: * women who gave birth at a term ≥ 22 weeks' gestation or, if the term is unknown, to a fetus with a birth weight ≥ 500 g), * regardless of the type of delivery (vaginal or cesarean), * regardless of parity or fetal presentation, * and regardless of type of pregnancy (singleton or multiple). * and affiliated with French CNAMTS (salaried worker) health insurance. Exclusion criteria: Women who are: * minors, * who do not understand French, * who refuse to participate (did not sign consent), * and who did not give birth at the Clermont-Ferrand University Hospital Center maternity unit and were secondarily transferred there postpartum. For the partners: Inclusion criteria: * Partner of a woman who gave birth at a term ≥ 22 weeks of gestation or, if the term is unknown, to a fetus with a birth weight ≥ 500 g), * Regardless of the type of delivery (vaginal or cesarean), * Regardless of parity and fetal presentation, * And regardless of type of pregnancy (singleton or multiple), * And both partners are affiliated with French CNAMTS (salaried worker) health insurance. Exclusion criteria: * Partner of a woman who gave birth at a term \< 22 weeks of gestation or, if the term is unknown, to a fetus with a birth weight \< 500 g), * Partner who does not understand French, * Who refuses to participate (does not sign consent), * Partner who is a minor, * Protected adult, * Partner not present at the maternity ward (woman is divorced, separated, has no partner, or the partner is abroad or in prison or died during pregnancy), * And partners of women who gave birth outside the UHC and was transferred to it only secondarily in the postpartum period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Postpartum anxiety are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

postpartum depression Postpartum Hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Clermont-Ferrand

    Clermont-Ferrand, 63003, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.